EP3822262 - Bibliographic data
AGONISTES MUSCARINIQUES
| Last update | 25/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
Société NXERA PHARMA UK LIMITED Granta Park
Great Abington
CB21 6DG s
CAMBRIDGE, Cambridgeshire
Royaume-Uni
|
|---|---|
| (72) Inventors |
Giles Albert BROWN C/o Heptares Therapeutics Limited
Granta Park
Great Abington
Cambridge, CB21 6DG
Royaume-Uni
Miles Stuart CONGREVE C/o Heptares Therapeutics Limited
Granta Park
Great Abington
Cambridge, CB21 6DG
Royaume-Uni
Mark PICKWORTH C/o Heptares Therapeutics Limited
Granta Park
Great Abington
Cambridge, CB21 6DG
Royaume-Uni
Benjamin Gerald TEHAN C/o Heptares Therapeutics Limited
Granta Park
Great Abington
Cambridge, CB21 6DG
Royaume-Uni
|
| (74) Agent |
Mail recipient Mewburn Ellis LLP Aurora Building
Counterslip
Bristol BS1 6BX
Royaume-Uni
|
| (21) Request number | EP20213929.1 |
|---|---|
| (22) Request date | 03/08/2016 |
| (11) Publication number | EP3822262 |
|---|---|
| Publication date | 27/03/2024 |
| (54) Title of the invention | AGONISTES MUSCARINIQUES |
|---|---|
| (51) International classification | C07D 401/04, C07D 401/08, A61P 25/00, A61P 25/02, A61P 25/04, A61P 25/14, A61P 25/18, A61P 25/28, A61P 25/30, A61P 29/00, A61P 43/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201513742 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 9 -
Amount: 175 € -
Due date 02/09/2024
Surtax: 9 - Amount: 35 € - Due date 03/03/2025 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 27/03/2024 Modification des titulaires du brevet européen - Legal date 17/05/2024 Entrée en période de grâce du brevet d'invention - Legal date 03/09/2024 Déchéance du brevet d'invention après période de grâce - Legal date 02/09/2024 |